SEC Filing Details

Document Details

Form
Filing Date
09-23-2020
Document Date
09-23-2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Taysha Gene Therapies
Issuer
TAYSHA GENE THERAPIES, INC.